5.73
price down icon1.88%   -0.11
after-market After Hours: 5.73
loading

Emergent Biosolutions Inc Stock (EBS) Latest News

pulisher
04:44 AM

Emergent BioSolutions New Hire Equity Grant Under NYSE Rule 303A.08 - The Manila Times

04:44 AM
pulisher
04:30 AM

Just Awarded: Emergent BioSolutions Grants Major 72,882 Share Package to Strategic New Hire - StockTitan

04:30 AM
pulisher
09:30 AM

Emergent BioSolutions: Attractive Biotech With Proven Business Clouded By Washington Funding Issues - Seeking Alpha

09:30 AM
pulisher
08:18 AM

Hikma announces Health Canada approval of KLOXXADO® (naloxone HCl) Nasal Spray 8 mg - The Manila Times

08:18 AM
pulisher
08:06 AM

Breakthrough: New High-Dose Naloxone Spray Gets Health Canada Green Light as Overdose Crisis Persists - StockTitan

08:06 AM
pulisher
05:00 AM

Syngene concludes acquisition of biologics manufacturing facility from Emergent BioSolutions - Medical Dialogues

05:00 AM
pulisher
Mar 19, 2025

Emergent BioSolutions sells Baltimore facility to Syngene By Investing.com - Investing.com South Africa

Mar 19, 2025
pulisher
Mar 19, 2025

Emergent BioSolutions Completes Sale of Baltimore-Bayview Facility to Syngene International - Marketscreener.com

Mar 19, 2025
pulisher
Mar 19, 2025

Emergent BioSolutions sells Baltimore facility to Syngene - Investing.com India

Mar 19, 2025
pulisher
Mar 19, 2025

Emergent Biosolutions finalizes sale of Baltimore-Bayview manufacturing site to Syngene International - Marketscreener.com

Mar 19, 2025
pulisher
Mar 19, 2025

Emergent BioSolutions Finalizes Sale of Baltimore-Bayview Manufacturing Site to Syngene International - The Manila Times

Mar 19, 2025
pulisher
Mar 19, 2025

Emergent BioSolutions Strategic Win: $36.5M Facility Sale While Securing Future Production Rights - StockTitan

Mar 19, 2025
pulisher
Mar 19, 2025

Syngene concludes the acquisition of Biologics Manufacturing Facility from Emergent BioSolutions Inc. - Equity Bulls

Mar 19, 2025
pulisher
Mar 18, 2025

Emergent BioSolutions secures $27 million in MCM orders - Investing.com

Mar 18, 2025
pulisher
Mar 18, 2025

Emergent BioSolutions Announces Approximately $27 Million in Incremental Sales to Supply International Customers with Five Critical Medical Countermeasure Products - The Manila Times

Mar 18, 2025
pulisher
Mar 18, 2025

Emergent BioSolutions Expands Global Reach with $27M Medical Defense Deal - StockTitan

Mar 18, 2025
pulisher
Mar 14, 2025

India-based Syngene acquires its first US biologics site - Manufacturing Dive

Mar 14, 2025
pulisher
Mar 14, 2025

Emergent BioSolutions to invest in Rocketvax for vaccine developments - MSN

Mar 14, 2025
pulisher
Mar 14, 2025

Emergent BioSolutions to sell Baltimore-Bayview manufacturing site for $36.5M - MSN

Mar 14, 2025
pulisher
Mar 13, 2025

Emergent signs financial investment agreement with Swiss Rockets - Yahoo

Mar 13, 2025
pulisher
Mar 13, 2025

Emergent BioSolutions Reinforces its Commitment to Expanding Access to NARCAN® Nasal Spray by Supporting Organizations with New Opioid Overdose Preparedness Programs - The Manila Times

Mar 13, 2025
pulisher
Mar 13, 2025

Emergent BioSolutions Reinforces its Commitment to Expanding Access to NARCAN® Nasal Spray by ... - The Bakersfield Californian

Mar 13, 2025
pulisher
Mar 13, 2025

First OTC Narcan Program Targets High-Risk Construction Workers to Combat Overdose Crisis - StockTitan

Mar 13, 2025
pulisher
Mar 12, 2025

Emergent BioSolutions director Zoon sells $57,300 in stock By Investing.com - Investing.com Australia

Mar 12, 2025
pulisher
Mar 12, 2025

Emergent BioSolutions director Fowler sells $204,050 in stock By Investing.com - Investing.com Australia

Mar 12, 2025
pulisher
Mar 12, 2025

Emergent BioSolutions director Fowler sells $204,050 in stock - Investing.com India

Mar 12, 2025
pulisher
Mar 12, 2025

Emergent BioSolutions director Zoon sells $57,300 in stock - Investing.com

Mar 12, 2025
pulisher
Mar 12, 2025

Emergent Bio and Rocketvax in investment deal and partnership - The Pharma Letter

Mar 12, 2025
pulisher
Mar 12, 2025

Emergent BioSolutions and Rocketvax Announce Investment Agreement - Contract Pharma

Mar 12, 2025
pulisher
Mar 12, 2025

Emergent Biosolutions And Rocketvax Announce Investment Agreement And Pursuit Of A Strategic Relationship For Next-Generation Product Candidates - Marketscreener.com

Mar 12, 2025
pulisher
Mar 12, 2025

Emergent BioSolutions to Invest in Swiss Rockets, Rocketvax -March 12, 2025 at 08:40 am EDT - Marketscreener.com

Mar 12, 2025
pulisher
Mar 12, 2025

Emergent BioSolutions, Rocketvax announce investment agreement - TipRanks

Mar 12, 2025
pulisher
Mar 12, 2025

Emergent BioSolutions and Rocketvax Ltd Announce Strategic Investment and Partnership to Advance Next-Generation Vaccine Development - Nasdaq

Mar 12, 2025
pulisher
Mar 12, 2025

Emergent BioSolutions and Rocketvax Announce Investment - GlobeNewswire

Mar 12, 2025
pulisher
Mar 12, 2025

Emergent BioSolutions and Rocketvax Announce Investment Agreement and Pursuit of a Strategic Relationship for Next-Generation Product Candidates - GlobeNewswire Inc.

Mar 12, 2025
pulisher
Mar 11, 2025

Rhumbline Advisers Trims Stock Position in Emergent BioSolutions Inc. (NYSE:EBS) - Defense World

Mar 11, 2025
pulisher
Mar 11, 2025

Syngene buys its first manufacturing facility in US for USD36.5 million - Medical Dialogues

Mar 11, 2025
pulisher
Mar 11, 2025

India's Syngene International acquires first US biologics facility for $36.5 mln - Reuters

Mar 11, 2025
pulisher
Mar 10, 2025

Emergent BioSolutions Sells Baltimore Facility to Syngene - TipRanks

Mar 10, 2025
pulisher
Mar 10, 2025

Gaithersburg's Emergent BioSolutions to sell Baltimore plant for $36.5M - Washington Business Journal

Mar 10, 2025
pulisher
Mar 10, 2025

Drug manufacturer to sell Baltimore plant for $36.5M - The Business Journals

Mar 10, 2025
pulisher
Mar 10, 2025

Emergent BioSolutions drops after Syngene buys co's unit for $36.5 mln - TradingView

Mar 10, 2025
pulisher
Mar 10, 2025

India's Syngene International acquires first US biologics facility for $36.5 million - Yahoo Finance

Mar 10, 2025
pulisher
Mar 10, 2025

Emergent to Sell Baltimore-Bayview Facility for $36.5 Million -March 10, 2025 at 10:28 am EDT - Marketscreener.com

Mar 10, 2025
pulisher
Mar 10, 2025

Emergent BioSolutions Announces Sale of Baltimore-Bayview Manufacturing Site to Syngene International - citybiz

Mar 10, 2025
pulisher
Mar 10, 2025

Emergent BioSolutions to sell Baltimore-Bayview facility for $36.5M - TipRanks

Mar 10, 2025
pulisher
Mar 10, 2025

Emergent BioSolutions Divests Baltimore Plant While Securing Future Production Rights - StockTitan

Mar 10, 2025
pulisher
Mar 07, 2025

Emergent BioSolutions’ (EBS) Buy Rating Reiterated at HC Wainwright - Defense World

Mar 07, 2025
pulisher
Mar 07, 2025

Q1 Earnings Estimate for EBS Issued By HC Wainwright - Defense World

Mar 07, 2025
pulisher
Mar 06, 2025

Emergent BioSolutions Inc. (NYSE:EBS) Consensus Forecasts Have Become A Little Darker Since Its Latest Report - Yahoo Finance

Mar 06, 2025
pulisher
Mar 05, 2025

Is Emergent BioSolutions (NYSE:EBS) Weighed On By Its Debt Load? - Simply Wall St

Mar 05, 2025
$10.58
price down icon 2.31%
$33.92
price down icon 1.22%
$98.85
price down icon 4.29%
$110.07
price down icon 0.22%
$9.44
price up icon 0.21%
$131.60
price up icon 0.05%
Cap:     |  Volume (24h):